Schedule 13D ownership disclosure
FUSION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 36118A100
Event date: 2023-05-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-23-000590
- Form type
- SC 13D
- Filer
- Fusion Pharmaceuticals Inc.
- CIK
- CIK 1805890
- Filed
- May 16, 2023
- Reporting period
- May 11, 2023
- Description
- Schedule 13D beneficial ownership